Founded by a psychiatrist · Clinician-led assessment · In development
Structured psychiatric assessment, designed for access.
Status SaMD in development Health Canada authorization pending Not yet authorized for clinical use
Assessment pathway
First intended use · Adult ADHD assessment
Evidence gathered
- 01 Guided intake
- 02 Structured screening
- 03 Structured interview
04 · The human acts here
A psychiatrist reviews every case
before any diagnosis is finalized.
How Limbus works, and why it is rigorous.
A guided pathway from intake to a psychiatrist-reviewed report. Conservative by design.
See how it works For investorsThe vision, the market, and the founder.
The structural gap in psychiatric access, the opportunity, and who is building Limbus.
See the opportunityFor investors · The opportunity
Psychiatric assessment has not scaled with the need.
The bottleneck is not demand. It is specialist capacity. The numbers describe a structural gap, not a marketing angle.
26 weeks
Median wait for psychiatric assessment in Canada
Fraser Institute
70 %
Of referrals psychiatrists are unable to accept
Vancouver referral study
6.7 M
Canadians without a family physician
Statistics Canada
2.5 M
Canadians with unmet mental-health needs
CMHA
Limbus is building clinician-led AI infrastructure for psychiatric assessment, designed to conduct structured assessment at scale and hand clinicians a psychiatrist-reviewed report. The aim is to widen access to assessment without lowering the bar on clinical rigor.
Built by a practicing psychiatrist, Limbus is a specialist-built system — not a wellness app and not an autonomous diagnostic engine. A human clinician stays in the loop on every case by design.
The platform
One platform, from assessment to therapy.
Limbus is clinical AI infrastructure for mental health. Two products, one clinician-supervised pipeline. A clinician stays in the loop at every step.
From referral to report, without the wait.
A structured psychiatric assessment pathway designed around 10 standardized instruments and Bayesian reasoning across 22 conditions, with every report reviewed by a psychiatrist before it reaches the referring physician.
See how Assess worksEvidence-based therapy, guided by AI and overseen by your clinician.
Evidence-based psychotherapy beginning with ERP for OCD and extending to IPT, CBT, and ACT, designed for delivery with real-time clinician oversight and progress tracking, so care can continue without a gap after assessment.
Follow our progressLimbus Assess · How it works
A guided assessment pathway, reviewed by a psychiatrist.
Limbus Assess is in development. It is designed to support clinicians through a structured assessment pathway, not to make autonomous diagnoses.
Evidence gathered · three inputs
- 01
Guided intake
A person completes a structured, plain-language intake at their own pace, capturing history, context, and presenting concerns.
- 02
Structured screening
Validated screening instruments are administered systematically, with built-in validity and safety checks rather than a single questionnaire.
- 03
AI-led clinical interview
A structured interview gathers the detail a clinician would ask for, following established assessment frameworks rather than improvising.
Reviewed · the human acts here
Psychiatrist-reviewed report
A psychiatrist reviews the assembled evidence and a structured summary of the findings. Every case is reviewed by a psychiatrist before any diagnosis is finalized.
Human in the loop, by design. The AI assembles and structures evidence; a psychiatrist makes the clinical call. Limbus is intended to give clinicians better-organized information — never to replace their judgment.
Human in the loop · Illustration
Watch the loop happen.
A fictional example — not output from the Limbus system — showing how it is designed to work: the system drafts and organizes the evidence; a psychiatrist questions it, corrects it, and decides.
Limbus Assess · Draft formulation
Presenting concern: 6-month low mood, fatigue, and reduced concentration; self-referred.
Screening: PHQ-9 16 (mod–severe) · GAD-7 11 (moderate) · ASRS below threshold · C-SSRS no active ideation.
Draft impression: major depressive episode, moderate–severe (confidence: high).
Contributing factor: sleep disturbance attributed to low mood.
Working differential: unipolar depression.
Routed to the reviewing psychiatrist with the full evidence trail.
Reviewed and countersigned by a psychiatrist.
Every case, by design — a design principle of a device in development, not a performance claim.
Fictional example for illustration · Limbus is in development and not authorized for clinical use
Clinical credibility
Clinical rigor is built into the design, not added on top.
Limbus is being built to clinical standards from the inside out. These are design principles for a device still in development, not claims of clinical performance.
RIGOR-01
Bayesian-rigorous reasoning
Assessment is treated as evidence accumulation, not pattern-matching. Findings update a structured clinical picture rather than producing a black-box label.
RIGOR-02
Validity & safety gates
Built-in checks flag inconsistent responses, risk indicators, and cases that fall outside intended scope, surfacing them for clinician attention.
RIGOR-03
Every case psychiatrist-reviewed
No diagnosis is finalized without a psychiatrist reviewing the evidence and formulation. The clinician owns the clinical decision.
RIGOR-04
Conservative by design
Where evidence is uncertain, Limbus is built to say so, and to defer to the reviewing clinician rather than over-claim.
RIGOR-01 to -04 are our own design-principle identifiers for the system’s clinical-rigor framework. They are internal references, not external certifications.
SaMD in development · Health Canada authorization pending · not a substitute for clinical judgment
The founder
Dr. Marie Claire Bourque
MD, FRCPC
Psychiatrist · Founder of Limbus
A psychiatrist building the infrastructure she wished existed.
Dr. Marie Claire Bourque is a Royal College–certified psychiatrist practicing in British Columbia and Ontario. She has spent her career on the front line of the access gap: in emergency departments, on inpatient wards, and in outpatient assessment, where the wait for specialist care is measured in months.
Limbus grew out of that work. Rather than wait for the system to train its way out of a shortage, she set out to build clinician-led infrastructure that brings structure and rigor to assessment, and is writing the system herself, pairing clinical judgment with the engineering to deliver it.
"The goal isn't to take the psychiatrist out of the room. It's to make sure the room exists — and that the clinician walks in with the evidence already organized."
Questions
Answers for everyone reading this page.
For clinicians
Does Limbus make diagnoses on its own?
No. Limbus assembles and structures assessment evidence and drafts a formulation; a psychiatrist reviews every case before any diagnosis is finalized. It is designed to support clinical judgment, not to replace it.
Is Limbus authorized for clinical use?
Not yet. Limbus is a software medical device in development. Authorization from Health Canada is pending, and Limbus is not yet authorized for clinical use (as of June 2026).
How does it stay rigorous?
Through validated structured instruments, built-in validity and safety gates, Bayesian-rigorous reasoning, and mandatory psychiatrist review of every case.
For patients & families
Can I use Limbus now?
Not yet. Limbus is in development. You can join the waitlist to be notified as it moves toward availability.
Will Limbus diagnose me?
No. Limbus is designed to support a clinician’s assessment, with a psychiatrist reviewing the evidence. It is not an autonomous diagnostic tool and is not a substitute for care from your own clinician.
What happens to my information?
For the waitlist we collect your email and your consent record, plus a non-reversible hashed token used only to prevent spam — all stored in infrastructure we control, and deleted whenever you ask. Details are in our privacy policy.
For press
What is Limbus, in one line?
Limbus is clinical AI infrastructure for mental health, in development, designed so every case is reviewed by a psychiatrist before any diagnosis is finalized.
What’s the difference between Limbus Assess and Limbus Therapy?
Limbus Assess is the psychiatric-assessment pathway (our current focus); Limbus Therapy is planned AI-delivered, clinician-overseen evidence-based therapy. Both are in development, with a clinician supervising throughout.
Who is behind it?
Limbus is founded by Dr. Marie Claire Bourque, MD, FRCPC, a practicing psychiatrist. A full press kit — boilerplate, fact sheet, logos, and founder material — is at limbushealth.ai/press.
For investors
Who built Limbus — is the founder technical?
Dr. Marie Claire Bourque, MD, FRCPC, is the founder and sole developer — a practicing psychiatrist writing both the clinical framework and the software. The product is built by the clinician who designed it.
Where can I learn more about the opportunity?
An investor overview and a deck request are at limbushealth.ai/investors.
Where does Limbus stand with Health Canada?
Limbus is a software medical device in development. Authorization from Health Canada is pending, and Limbus is not yet authorized for clinical use (as of June 2026).
For hires & partners
Are you hiring or partnering?
Limbus is an early, specialist-built effort. For roles, clinical partnerships, or pilot discussions, please get in touch.
How can health systems get involved?
We welcome conversations with clinics and health systems interested in the assessment-access problem. Reach out via the contact path below.
Get in touch
We would like to hear from you.
Whether you are an investor, a clinician or partner, or a journalist, there is a direct line below.
Clinicians, partners & press
Clinicians, clinics, health systems, pilots, and media are all welcome.
[email protected]Register interest
Join the waitlist and be among the first to know as Limbus opens.
Join the waitlist for product updates and early access as Limbus moves toward authorization. Email only, with your consent, stored in infrastructure we control, never shared, and you can unsubscribe anytime.
Request recorded · confirmation sent
Almost there — check your inbox to confirm your email.
Double opt-in: your address isn’t added until you click the link we just sent. The link expires in 24 hours.
After you confirm, we’ll only reach out when there’s something real — product milestones and access opening. No newsletters.
Status In development Pending regulatory authorization Not a diagnostic device